Tag Archives: TCR engineered T cell

26Apr/24

High-throughput Discovery of Tumor-Reactive T Cell Receptors: Advancing Personalized Cellular Immunotherapy

April 26, 2024Cancer Immunotherapy, TCR ResearchPersonalized Cellular Immunotherapy, TCR engineered T cell, Tumor-Reactive T Cell Receptorbiocart

T-cell receptor (TCR) gene therapy is a form of cellular immunotherapy where peripheral blood T cells from cancer patients are genetically engineered ex vivo to express tumor-specific TCRs before being reintroduced intoRead More…

04Jan/18

Literature Reading: Driving Gene-engineered T Cell Immunotherapy of Cancer

January 4, 2018Chimeric Antigen Receptor ResearchCAR-T, CD19-targeted CARs, Chimeric antigen receptor (CAR), Global CAR-T clinical trial review, TCR engineered T cellbiocart

This is a review article published on Cell Research (2017) 27: 38-58 by Laura A Johnson and Carl H June. Dr. Carl H. June is the director of translational research at the Abramson Cancer CenterRead More…

Chimeric Antigen Receptor Research
TCR Research
Oncolytic Virus Therapy Research
News